Skip to content

Trials and studies underway or in preparation in France

Taking part in a clinical trial can provide an opportunity to benefit from innovative treatments and contribute to scientific research. Here is a table of clinical trials currently underway or in preparation for mitochondrial diseases in France.

There are no clinical trials currently available.

The trial begins Par testing the drug on a small healthy group. The aim is to assess its safety, side effects and ideal dose.

The drug is administered to patients with the targeted disease. This step measures efficacy and refines safety.

The drug is tested on a large number of patients to confirm its efficacy, monitor side effects and compare it with existing treatments.

After approval, the drug is monitored over the long term to detect any side effects and assess its benefits in real life.